Hospital or health organisation · founded 1913
City of Hope
Lancaster, United States · cityofhope.org/location/antelope-valley
- Citations, last 5 years
- 83.9k
- Works, last 5 years
- 7 099
- h-index
- 595
- Scientists listed
- 36
- Grants since 2016
- 654
Grants received
2023–2028 · career development · K08
Determinants of Resistance to Engineered T-cell Therapies Targeting CD19 in Lymphoma
Brian Sworder · City of Hope · funded by National Institutes of Health
2023–2027 · cooperative agreement · U01
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
David Horne · City of Hope · funded by National Institutes of Health
2023–2028 · research · R01
Targeting Immune Escape in CML/MPN Transformation
Guido Marcucci · City of Hope · funded by National Institutes of Health
2023–2028 · research · R01
Exosomal biomarkers for the early detection of hepatocellular carcinoma
Ajay Goel · City of Hope · funded by National Institutes of Health
2023–2028 · research · R01
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
Behnam Badie · City of Hope · funded by National Institutes of Health
2023–2028 · research · R01
Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation
Don J Diamond · City of Hope · funded by National Institutes of Health
2023–2028 · training · T32
DIABETES PREVENTION / RISK / OMICS / METABOLISM / THERAPY (PROMT) INTERDISCIPLINARY TRAINING
Rama Natarajan · City of Hope · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
Ernest Martinez · City of Hope · funded by National Institutes of Health
2023–2025 · research · R37
Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia
Chun-Wei David Chen · City of Hope · funded by National Institutes of Health
2023–2028 · research · R01
Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia
Ling Li · City of Hope · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Pilot Project 1
Victoria L. Seewaldt · City of Hope · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Core 4: Shared Resource - Capacity Development
Victoria L. Seewaldt · City of Hope · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Project 1
Veronica Christine Jones · City of Hope · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Core 2: Research Education
Tijana Talisman · City of Hope · funded by National Institutes of Health
2022–2023 · research · R21
Targeting MUC16 transactivation for ovarian cancer treatment
Edward Wenge Wang · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Mechanism and therapeutic opportunities of targeting the Tudor domain
Chun-Wei David Chen · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Integration of epidemiology, pathology, immunology and outcomes in colorectal cancer
Stephen B Gruber · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer
Sunita K Patel · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
Anna M Wu · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer
Sunita K Patel · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
Jianjun Chen · City of Hope · funded by National Institutes of Health
2022–2024 · research · R21
Integrated Genotypic, Phenotypic and Immunologic Analysis of Ethnically Diverse Prostate Cancers
Tanya Dorff · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRs
Andrei Rodin · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
Susan L. Neuhausen · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
Guido Marcucci · City of Hope · funded by National Institutes of Health
2022–2028 · research · R01
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
Stephen J Forman · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
Edwin Manuel · City of Hope · funded by National Institutes of Health
2022–2025 · research · R21
Genomic Analysis of Cutaneous CD30+ Lymphoproliferative Disorders
Christiane Querfeld · City of Hope · funded by National Institutes of Health
2022–2023 · career development · K76
Targeting Senescence to Improve Frailty in Older Cancer Survivors
Mina S Sedrak · City of Hope · funded by National Institutes of Health
2022–2025 · research · R21
Integrated Genotypic, Phenotypic and Immunologic Analysis of Ethnically Diverse Prostate Cancers
Tanya Dorff · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
Jianjun Chen · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
Susan L. Neuhausen · City of Hope · funded by National Institutes of Health
2022–2023 · fellowship · F99
Targeting a Novel Pocket on ITGAV
Nicole Mattson · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer
Edwin Manuel · City of Hope · funded by National Institutes of Health
2022–2025 · research · R21
A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy
Richard T Lee · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis
Sally Choate Kent · City of Hope · funded by National Institutes of Health
2022–2026 · research · R01
Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling
Zhao Wang · City of Hope · funded by National Institutes of Health
2022–2027 · research · R01
Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer
Edwin Manuel · City of Hope · funded by National Institutes of Health
2022–2025 · research · R21
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
Jeffrey Y Wong · City of Hope · funded by National Institutes of Health
2022–2027 · grant · DP5
Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis
Yun Rose Li · City of Hope · funded by National Institutes of Health